BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62 | +77.1% | 2,661 | -87.8% | 0.01% | +40.0% |
| Q2 2023 | $35 | -90.5% | 21,800 | +10.6% | 0.01% | -86.8% |
| Q1 2023 | $369 | +251.4% | 19,714 | +48.6% | 0.04% | +322.2% |
| Q4 2022 | $105 | -100.0% | 13,267 | -56.3% | 0.01% | -77.5% |
| Q3 2022 | $595,000 | -63.0% | 30,371 | -49.0% | 0.04% | -64.3% |
| Q2 2022 | $1,606,000 | +368.2% | 59,526 | +29.4% | 0.11% | +522.2% |
| Q1 2022 | $343,000 | -6.5% | 46,009 | +345.0% | 0.02% | +12.5% |
| Q4 2021 | $367,000 | -10.0% | 10,339 | -9.7% | 0.02% | -11.1% |
| Q3 2021 | $408,000 | +2.8% | 11,448 | +8.2% | 0.02% | 0.0% |
| Q2 2021 | $397,000 | +36.0% | 10,583 | +21.6% | 0.02% | +28.6% |
| Q1 2021 | $292,000 | -49.0% | 8,703 | -20.6% | 0.01% | -48.1% |
| Q4 2020 | $572,000 | +157.7% | 10,963 | +296.8% | 0.03% | +92.9% |
| Q3 2020 | $222,000 | +66.9% | 2,763 | -41.1% | 0.01% | +55.6% |
| Q2 2020 | $133,000 | +6.4% | 4,689 | +2.2% | 0.01% | +50.0% |
| Q1 2020 | $125,000 | -84.5% | 4,589 | -86.9% | 0.01% | -87.8% |
| Q4 2019 | $804,000 | +402.5% | 35,113 | +298.1% | 0.05% | +226.7% |
| Q3 2019 | $160,000 | -48.2% | 8,820 | -16.8% | 0.02% | -48.3% |
| Q2 2019 | $309,000 | -42.2% | 10,606 | -25.9% | 0.03% | -47.3% |
| Q1 2019 | $535,000 | +11.5% | 14,306 | +6.4% | 0.06% | +22.2% |
| Q4 2018 | $480,000 | +37.5% | 13,450 | +15.9% | 0.04% | +95.7% |
| Q3 2018 | $349,000 | +2584.6% | 11,600 | +1188.9% | 0.02% | +2200.0% |
| Q2 2018 | $13,000 | +8.3% | 900 | -94.3% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | -7.7% | 15,900 | +835.3% | 0.00% | – |
| Q4 2017 | $13,000 | -65.8% | 1,700 | -66.5% | 0.00% | -100.0% |
| Q3 2017 | $38,000 | -89.6% | 5,076 | -23.1% | 0.00% | -92.3% |
| Q2 2017 | $367,000 | +1083.9% | 6,602 | -2.9% | 0.01% | +1200.0% |
| Q1 2017 | $31,000 | +244.4% | 6,800 | -40.4% | 0.00% | – |
| Q4 2016 | $9,000 | -99.6% | 11,400 | -81.7% | 0.00% | -100.0% |
| Q3 2016 | $2,467,000 | -20.6% | 62,282 | -30.0% | 0.11% | -29.3% |
| Q2 2016 | $3,107,000 | +1205.5% | 88,991 | +976.7% | 0.16% | +881.2% |
| Q1 2016 | $238,000 | -75.8% | 8,265 | -89.0% | 0.02% | -70.4% |
| Q4 2015 | $984,000 | – | 75,365 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |